MX9304608A - Nuevas (n-metanosulfonil)-quinolilmetoxifenil-cicoalquilacetamidas sustituidas por isobutilo, procedimiento para su preparacion y medicamentos que las contienen. - Google Patents

Nuevas (n-metanosulfonil)-quinolilmetoxifenil-cicoalquilacetamidas sustituidas por isobutilo, procedimiento para su preparacion y medicamentos que las contienen.

Info

Publication number
MX9304608A
MX9304608A MX9304608A MX9304608A MX9304608A MX 9304608 A MX9304608 A MX 9304608A MX 9304608 A MX9304608 A MX 9304608A MX 9304608 A MX9304608 A MX 9304608A MX 9304608 A MX9304608 A MX 9304608A
Authority
MX
Mexico
Prior art keywords
substituted
new
quinolylmetoxifenil
methanosulfonil
isobutilo
Prior art date
Application number
MX9304608A
Other languages
English (en)
Inventor
Romanis Fruchtmann
Reiner Muller-Peddinghaus
Armin Hatzelmann
Siegfried Raddatz
Klaus-Helmut Mohrs
Michael Matzke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX9304608A publication Critical patent/MX9304608A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Las nuevas (N-metanosulfonil)-quinolilmetoxifenil-clicloalqui lacetaminas sustituídas por isobutilo, se pueden obtener por transformación de los correspondientes ácidos, racémicos o enantiómeros, con metanosulfonamida, donde los productos finales racémicos pueden separarse en los enantiómeros puros siguiendo métodos habituales. Las (N-metanosulfonil)-quinolilmetoxifenil-cicloalquil acetamidas sustituídas por isobutilo puede emplearse como sustancias activas en medicamentos.
MX9304608A 1992-08-12 1993-07-30 Nuevas (n-metanosulfonil)-quinolilmetoxifenil-cicoalquilacetamidas sustituidas por isobutilo, procedimiento para su preparacion y medicamentos que las contienen. MX9304608A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226649A DE4226649A1 (de) 1992-08-12 1992-08-12 Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole

Publications (1)

Publication Number Publication Date
MX9304608A true MX9304608A (es) 1994-02-28

Family

ID=6465373

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304608A MX9304608A (es) 1992-08-12 1993-07-30 Nuevas (n-metanosulfonil)-quinolilmetoxifenil-cicoalquilacetamidas sustituidas por isobutilo, procedimiento para su preparacion y medicamentos que las contienen.

Country Status (19)

Country Link
EP (1) EP0582916A1 (es)
JP (1) JPH06157462A (es)
KR (1) KR940003937A (es)
CN (1) CN1039998C (es)
AU (1) AU669913B2 (es)
CA (1) CA2103600A1 (es)
CZ (1) CZ282341B6 (es)
DE (1) DE4226649A1 (es)
FI (1) FI933529A (es)
HU (1) HUT70171A (es)
IL (1) IL106623A0 (es)
MX (1) MX9304608A (es)
MY (1) MY108716A (es)
NO (1) NO179948C (es)
NZ (1) NZ248350A (es)
PL (1) PL174102B1 (es)
RU (1) RU2103261C1 (es)
SK (1) SK86693A3 (es)
ZA (1) ZA935828B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US5931170A (en) * 1998-10-08 1999-08-03 Addway Engineering Limited Dental flosser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren

Also Published As

Publication number Publication date
NO179948C (no) 1997-01-15
FI933529A0 (fi) 1993-08-10
JPH06157462A (ja) 1994-06-03
KR940003937A (ko) 1994-03-14
SK86693A3 (en) 1994-09-07
EP0582916A1 (de) 1994-02-16
IL106623A0 (en) 1993-12-08
AU669913B2 (en) 1996-06-27
CN1039998C (zh) 1998-09-30
NO932731D0 (no) 1993-07-29
HUT70171A (en) 1995-09-28
FI933529A (fi) 1994-02-13
AU4425593A (en) 1994-02-17
CZ163693A3 (en) 1994-03-16
PL174102B1 (pl) 1998-06-30
NZ248350A (en) 1994-12-22
MY108716A (en) 1996-11-30
NO932731L (no) 1994-02-14
CN1087084A (zh) 1994-05-25
RU2103261C1 (ru) 1998-01-27
CA2103600A1 (en) 1994-02-13
PL300025A1 (en) 1994-03-21
ZA935828B (en) 1994-03-10
CZ282341B6 (cs) 1997-07-16
NO179948B (no) 1996-10-07
DE4226649A1 (de) 1994-02-17
HU9302320D0 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
BG94619A (bg) Метод за изпаряване на съединения,използвани за нанасянето им под формата на пари
ES2021699B3 (es) Proceso para la preparacion de esteres.
NO862734D0 (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
ES2052645T3 (es) Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen.
PT90382A (pt) Processo para a preparacao de acidos e esteres 4-(quinolin-2-il-metoxi)fenila ceticos alfa-substituidos
ES2189782T3 (es) Derivados de pteridina opticamente activos.
PT93959A (pt) Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima
NO167213C (no) Komposittartikkel i form av en innlukningsgjenstand, samtfremgangsmaate for sulfonering av den innvendige overflateav en innlukningsgjenstand.
SE7602751L (sv) Framstellning av n-acyl-l-metionin
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
ES2059492T3 (es) Procedimiento para la preparacion de ibuprofen.
DE69009237D1 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
MX9302487A (es) Piridonas sustituidas por bifenilmetilo, procedimiento para su obtencion y medicamentos que las contienen.
PT87642A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors
JPS5417744A (en) Linear lighting method
ES2025122B3 (es) Procedimiento para obtencion de esteres de acidos alquencarboxilicos.
SE8801710L (sv) New ophtalmological composition of matter
PT98121A (pt) Processo para a preparacao de novos 3,3'-ditio-bis (acidos propionicos) e seus esteres e de composicoes farmaceuticas que os contem
MX9304608A (es) Nuevas (n-metanosulfonil)-quinolilmetoxifenil-cicoalquilacetamidas sustituidas por isobutilo, procedimiento para su preparacion y medicamentos que las contienen.
ES492142A0 (es) Procedimiento para la produccion de oxidasa de alcohol
ES540213A0 (es) Procedimiento para la obtencion de esteres del acido salici-lico, de efecto perfumante
IT1125487B (it) Procedimento perfezionato per la preparazione di idroperossidi aromatici
AR241108A2 (es) Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion
FR2389625A1 (es)